Specialized Medical Company (TADAWUL:4019)
Saudi Arabia · Delayed Price · Currency is SAR 18.16
-0.17 (-0.93%)
May 4, 2026, 3:19 PM AST
Specialized Medical Company Earnings Call Transcripts
Fiscal Year 2025
-
Strong revenue and profit growth in 2025 driven by acute and outpatient expansion, with a 43.7% rise in net profit and improved margins. Guidance for 2026 is conservative due to ramp-up delays and market competition, but expansion and capital discipline continue.
-
Q3 2025 saw strong revenue and profit growth, driven by a strategic shift to acute and outpatient services, with EBITDA margin rising to 27.3%. Expansion continues with new clinics and hospitals, a SAR 200 million special dividend, and robust guidance for year-end.